Our country researches and develops a kind of new medicine and ends so as to go on the market hard independently Treat the rheumatoid arthritis medicine for the global first small molecule

Our country researches and develops a kind of new medicine and ends so as to go on the market hard independently Treat the rheumatoid arthritis medicine for the global first small molecule
Our country researches and develops a kind of new medicine and ends so as to go on the market hard independently Treat the rheumatoid arthritis medicine for the global first small molecule
It is reported ' Reporter Xue Yuan) Last 12 year, invest several hundred million research and develop, succeed, our country have independent global first little member of intellectual property right treat the rheumatoid arthritis medicine totally " End hard " --Aila and Maud is listed on January 8. This new medicine is by Tianjin medicine research institute and joint development of Pharmaceutcal Co., Ltd. of Jiangsu first sign, got a kind of new medicine certificate and registered written instructions or comments of medicines last August. At present, studying has already been included " twelve five " in the Ministry of Science and Technology after the ones that ended hard were listed Great new medicine formulates the great project support project of science and technology. Know the chestnut of immune head of the department of rheumatism of General Board, the People's Hospital of Peking University and take country's introduction in Chinese Medical Association's rheumatism credit, one of the supreme diseases that rheumatism, rheumatoid arthritis disable leading in the whole world, nearly 5 million patients need to treat in our country. At present, the clinical medicine that uses is treated by symptom, and store in and abuse hormone, analgesic,etc. unstandardly to treat the behavior, the therapeutic effect is unsatisfactory too. End so as to treat rheumatism, rheumatoid arthritis pepperily, the result can arise from quickest 4 weeks to 6 weeks, can inhibit many kinds of cell factors and expressions of the rheumatoid factor, obviously improve symptom and physical sign of the arthritis patient of rheumatoid. In addition, can also prevent to end hard effectively osseously and destroy and reduce the disabling and causing the lopsided rate of the patient.


|